Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

DSM Is in Exclusive Talks to Buy Cargill’s Cultures Unit

Sept. 20 (Bloomberg) -- Royal DSM NV, the world’s largest vitamin maker, said it’s in exclusive talks to buy Cargill Inc.’s cultures and enzymes business in an effort to gain a bigger share of a 1 billion-euro ($1.3 billion) market.

“A possible combination of the Cargill cultures and enzymes business with the dairy business of DSM Food Specialties would be highly complementary, creating a strong global player,” Heerlen, Netherlands-based DSM said in a statement today.

The Cargill division supplies the dairy and meat industries and has factories in Wisconsin and France, generating sales of about 45 million euros a year, DSM said. The acquisition would be the eighth by DSM’s nutrition unit since the Dutch company started transforming in 2010 from a commodity-chemical manufacturer into a maker of enzymes, specialty plastics and nutritional supplements, it said.

Industrywide demand for cultures and enzymes is growing steadily at more than 5 percent a year, DSM said.

To contact the reporter on this story: Maaike Noordhuis in Amsterdam at

To contact the editor responsible for this story: Benedikt Kammel at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.